Central and Peripheral GLP-1 Systems Independently Suppress Eating. Nature Metabolism, vol
Clinical studies consistently show that individuals treated with Ozempic can lose approximately 10-15% of their body weight, compared to the 5-10% often observed with liraglutide
Understanding each step helps set realistic expectations about timelines, provider interaction, and what happens after you start treatment
Potential Demand for GLP-1s According to the Centers for Disease Control (CDC), in 2021, 29.4 million adults in the United States were diagnosed with diabetes (90 to 95 percent were T2D)
Lets explore both sides: Negative Impact of GLP-1s on Mental Health While there is still much research being done, Dr Hobart shared that some studies suggest that GLP-1s could be associated with increased depression, anxiety, and even suicidal ideation